Journal of Applied Microbiology

PathO3Gen Solutions UVZone® Proven 99.9993% Effective Against Candida Auris: Shoes and Floors in Healthcare Facilities Should Be Addressed as Outbreak Continues

Retrieved on: 
Tuesday, April 11, 2023
Other Health, Managed Care, General Health, Medical Devices, Infectious Diseases, Hospitals, Construction & Property, Health Technology, Biotechnology, Building Systems, Practice Management, Health, Systematic review, Clostridioides difficile, Microbiology, Infection, Preventive healthcare, Long-term care, MRSA, NSF International, Escherichia coli, UVC, Multimedia, The Rehabilitation Center at Hollywood Hills, CDC, Candida auris, EPA, Nursing, Hospital, Journal, Patient, Infection Control & Hospital Epidemiology, Risk, Journal of Applied Microbiology, Ozone, Shoe, Centers for Disease Control and Prevention, Auris, Vaccine

PathO3Gen Solutions multi-patented UVZone® shoe sanitizing technology is proven to eliminate Candida auris up to 99.9993% in 10 seconds.

Key Points: 
  • PathO3Gen Solutions multi-patented UVZone® shoe sanitizing technology is proven to eliminate Candida auris up to 99.9993% in 10 seconds.
  • View the full release here: https://www.businesswire.com/news/home/20230411005067/en/
    The UVZone® Shoe Sanitizing Station is a multi-patented UV-C and Ozone disinfection technology utilizing Corning® HPFS® Fused Silica windows.
  • PathO3Gen Solutions’ multi-patented UVZone Shoe Sanitizing Stations, when placed in high-traffic and high-risk areas, enhance healthcare facility infection control measures, and may improve overall hospital biosafety.
  • Proven efficacy includes reductions up to 99.9960% for C. diff, 99.9969% for MRSA, 99.9986% for K. pneumoniae, 99.9989% for E. coli.

New Febreze Fabric Antimicrobial Helps American’s Kill Bacteria Living On Their Soft Surfaces

Retrieved on: 
Tuesday, October 26, 2021
Other Consumer, Home Goods, Consumer, Other Retail, Retail, Procter & Gamble, Ambi, Research, Shoe, University, Hospital, University of New England College of Osteopathic Medicine, P&G, CFU, Dust, Partnership, Charles P. Gerba, PETS, American Journal of Infection Control, MOE, Atmosphere, Osteopathic medicine in the United States, P, American Journal, Â, Maxwell, ISCB Senior Scientist Award, Growth, Multimedia, Bacteria, Journal of Applied Microbiology, News, MSRP, Infection, Enterococcus raffinosus, Parent, Disinfectant, Perspiration, 3D printing, Other Consumer, Home Goods, Consumer, Other Retail, Retail

View the full release here: https://www.businesswire.com/news/home/20211026005078/en/

Key Points: 
  • View the full release here: https://www.businesswire.com/news/home/20211026005078/en/
    New Febreze Fabric Antimicrobial (Photo: Business Wire)
    That may be because Americans believe that hard surfaces like their toilet seat (45%) host the most bacteria.
  • Enter Febrezes newest fabric refresher, Febreze Fabric Antimicrobial, a multi-purpose fabric spray that kills 99.9% of bacteria3, eliminates odors, and prevents the growth of mold and mildew on soft surfaces4.
  • Febreze created the new Febreze Fabric Antimicrobial to address both concerns sanitization and odor elimination- at the same time in one simple product.
  • The Febreze Fabric Antimicrobial Survey was conducted on behalf of Febreze in partnership with a trusted third-party vendor, among a sample of n=1,008 Americans.